Digest: November 2026
What changed in the US supplement label data in November 2026: label counts, rising and falling compounds and excipients, FDA enforcement records, and a finding from the data.
The label data
The NIH label database (DSLD) was last released on 2026-01-16. No new release has been published since the previous refresh, so the label counts are unchanged; the sections below that depend on a comparison between releases are left out rather than padded.
Who is moving
Momentum compares the number of products entered in the last 12 months with the 12 before. Above 1.0 is growing, below 1.0 is shrinking. Only items with at least 50 recent entries are ranked. See Trending for every compound and excipient.
Compounds appearing on more new labels
- Creatine: 1.39x (219 vs 157)
- Caffeine: 1.20x (674 vs 560)
- Beta-Alanine: 1.17x (334 vs 286)
Compounds appearing on fewer new labels
- Chondroitin Sulfate: 0.43x (79 vs 185)
- Glucosamine: 0.46x (101 vs 218)
- Collagen (Hydrolyzed Collagen Peptides): 0.54x (189 vs 348)
Excipients appearing on more new labels
- Glaze (unspecified): 2.18x (109 vs 50)
- China Wax: 1.89x (87 vs 46)
- Dextrin: 1.89x (363 vs 192)
Excipients appearing on fewer new labels
- Rice Powder: 0.22x (77 vs 347)
- Pullulan: 0.41x (97 vs 239)
- Lecithin: 0.45x (90 vs 202)
FDA enforcement
2 FDA enforcement records involving dietary supplements were reported in the 60 days before this edition, out of 686 in the snapshot. See the FDA Recalls report for how records are matched to labels and what they do not show.
- 2026-10-28 · EVEXIAS HEALTH SOLUTION · Class II: The product is mislabeled and fails to declare fish oil. H-0170-2027
- 2026-10-28 · Pacific Health Sciences Llc · Class II: Adulterated (elevated levels of alcohol) infant dietary supplement H-0168-2027
A finding from the data
Across 185 on-market gummy Thiamine (Vitamin B1) products, the median declared dose is 0.3 mg per serving, versus 8 mg for capsule/tablet versions — a 3.8% share, per the 2026-01-16 DSLD dump.